nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP2B6—malignant glioma	0.355	0.54	CbGaD
Mianserin—SLC6A3—malignant glioma	0.303	0.46	CbGaD
Mianserin—CYP1A2—Carmustine—malignant glioma	0.0544	0.57	CbGbCtD
Mianserin—CYP3A4—Temozolomide—malignant glioma	0.0411	0.43	CbGbCtD
Mianserin—HTR1D—meninx—malignant glioma	0.0125	0.103	CbGeAlD
Mianserin—HTR1D—dura mater—malignant glioma	0.0115	0.0952	CbGeAlD
Mianserin—HTR2C—choroid plexus—malignant glioma	0.00971	0.0802	CbGeAlD
Mianserin—DRD3—telencephalic ventricle—malignant glioma	0.00511	0.0422	CbGeAlD
Mianserin—HTR2A—choroid plexus—malignant glioma	0.00487	0.0402	CbGeAlD
Mianserin—SLC6A3—telencephalic ventricle—malignant glioma	0.00294	0.0243	CbGeAlD
Mianserin—HTR1D—telencephalic ventricle—malignant glioma	0.00287	0.0237	CbGeAlD
Mianserin—HTR2C—telencephalic ventricle—malignant glioma	0.00284	0.0235	CbGeAlD
Mianserin—HTR7—pons—malignant glioma	0.00278	0.023	CbGeAlD
Mianserin—HTR2A—cerebellar cortex—malignant glioma	0.00245	0.0203	CbGeAlD
Mianserin—HTR1A—telencephalic ventricle—malignant glioma	0.00239	0.0198	CbGeAlD
Mianserin—HTR7—telencephalic ventricle—malignant glioma	0.00229	0.0189	CbGeAlD
Mianserin—DRD2—telencephalic ventricle—malignant glioma	0.00216	0.0179	CbGeAlD
Mianserin—HTR1F—telencephalon—malignant glioma	0.00174	0.0144	CbGeAlD
Mianserin—HTR2A—pons—malignant glioma	0.00173	0.0143	CbGeAlD
Mianserin—HTR2A—vertebral column—malignant glioma	0.00172	0.0142	CbGeAlD
Mianserin—HTR2A—telencephalic ventricle—malignant glioma	0.00143	0.0118	CbGeAlD
Mianserin—HTR1D—blood vessel—malignant glioma	0.00142	0.0117	CbGeAlD
Mianserin—HTR2A—pineal body—malignant glioma	0.00124	0.0102	CbGeAlD
Mianserin—HTR7—endothelium—malignant glioma	0.00123	0.0101	CbGeAlD
Mianserin—Hepatic enzyme increased—Temozolomide—malignant glioma	0.0012	0.0335	CcSEcCtD
Mianserin—HTR6—telencephalon—malignant glioma	0.00118	0.00976	CbGeAlD
Mianserin—HTR7—blood vessel—malignant glioma	0.00113	0.00935	CbGeAlD
Mianserin—Gynaecomastia—Carmustine—malignant glioma	0.00105	0.0293	CcSEcCtD
Mianserin—HTR1F—central nervous system—malignant glioma	0.000988	0.00816	CbGeAlD
Mianserin—Nasal congestion—Temozolomide—malignant glioma	0.000902	0.0252	CcSEcCtD
Mianserin—Diplopia—Carmustine—malignant glioma	0.000851	0.0238	CcSEcCtD
Mianserin—Diplopia—Temozolomide—malignant glioma	0.000822	0.023	CcSEcCtD
Mianserin—SLC6A3—brainstem—malignant glioma	0.000796	0.00658	CbGeAlD
Mianserin—HTR1F—brain—malignant glioma	0.000785	0.00648	CbGeAlD
Mianserin—HTR1D—brainstem—malignant glioma	0.000777	0.00642	CbGeAlD
Mianserin—Amitriptyline—NTRK2—malignant glioma	0.000774	0.156	CrCbGaD
Mianserin—HTR2C—brainstem—malignant glioma	0.00077	0.00636	CbGeAlD
Mianserin—HTR2A—endothelium—malignant glioma	0.000766	0.00632	CbGeAlD
Mianserin—Breast disorder—Temozolomide—malignant glioma	0.000743	0.0208	CcSEcCtD
Mianserin—SLC6A4—brainstem—malignant glioma	0.00073	0.00603	CbGeAlD
Mianserin—SLC6A3—telencephalon—malignant glioma	0.000707	0.00584	CbGeAlD
Mianserin—HTR2A—blood vessel—malignant glioma	0.000706	0.00583	CbGeAlD
Mianserin—Pancytopenia—Carmustine—malignant glioma	0.000698	0.0195	CcSEcCtD
Mianserin—DRD3—central nervous system—malignant glioma	0.000698	0.00576	CbGeAlD
Mianserin—HTR1D—telencephalon—malignant glioma	0.00069	0.0057	CbGeAlD
Mianserin—Neutropenia—Carmustine—malignant glioma	0.000687	0.0192	CcSEcCtD
Mianserin—HTR2C—telencephalon—malignant glioma	0.000683	0.00564	CbGeAlD
Mianserin—Pancytopenia—Temozolomide—malignant glioma	0.000675	0.0189	CcSEcCtD
Mianserin—HTR6—central nervous system—malignant glioma	0.000672	0.00555	CbGeAlD
Mianserin—Neutropenia—Temozolomide—malignant glioma	0.000664	0.0186	CcSEcCtD
Mianserin—Erectile dysfunction—Temozolomide—malignant glioma	0.000654	0.0183	CcSEcCtD
Mianserin—HTR1A—brainstem—malignant glioma	0.000648	0.00535	CbGeAlD
Mianserin—SLC6A4—telencephalon—malignant glioma	0.000648	0.00535	CbGeAlD
Mianserin—Weight increased—Temozolomide—malignant glioma	0.000647	0.0181	CcSEcCtD
Mianserin—SLC6A2—brainstem—malignant glioma	0.000642	0.00531	CbGeAlD
Mianserin—HTR2B—telencephalon—malignant glioma	0.000642	0.0053	CbGeAlD
Mianserin—OPRK1—central nervous system—malignant glioma	0.000622	0.00514	CbGeAlD
Mianserin—HTR7—brainstem—malignant glioma	0.000619	0.00511	CbGeAlD
Mianserin—HRH2—central nervous system—malignant glioma	0.000614	0.00507	CbGeAlD
Mianserin—OPRK1—cerebellum—malignant glioma	0.000608	0.00502	CbGeAlD
Mianserin—Diphenylpyraline—SLC6A3—malignant glioma	0.000603	0.122	CrCbGaD
Mianserin—Hepatobiliary disease—Temozolomide—malignant glioma	0.000599	0.0168	CcSEcCtD
Mianserin—DRD2—brainstem—malignant glioma	0.000585	0.00483	CbGeAlD
Mianserin—Epinastine—CYP2B6—malignant glioma	0.000584	0.118	CrCbGaD
Mianserin—Connective tissue disorder—Carmustine—malignant glioma	0.000578	0.0162	CcSEcCtD
Mianserin—HTR1A—telencephalon—malignant glioma	0.000575	0.00475	CbGeAlD
Mianserin—SLC6A2—telencephalon—malignant glioma	0.00057	0.00471	CbGeAlD
Mianserin—Hepatitis—Temozolomide—malignant glioma	0.000569	0.0159	CcSEcCtD
Mianserin—DRD2—retina—malignant glioma	0.000565	0.00466	CbGeAlD
Mianserin—Connective tissue disorder—Temozolomide—malignant glioma	0.000559	0.0156	CcSEcCtD
Mianserin—DRD3—brain—malignant glioma	0.000554	0.00458	CbGeAlD
Mianserin—Eye disorder—Carmustine—malignant glioma	0.00055	0.0154	CcSEcCtD
Mianserin—HTR7—telencephalon—malignant glioma	0.000549	0.00454	CbGeAlD
Mianserin—HTR2C—medulla oblongata—malignant glioma	0.000537	0.00443	CbGeAlD
Mianserin—HTR6—brain—malignant glioma	0.000533	0.00441	CbGeAlD
Mianserin—Eye disorder—Temozolomide—malignant glioma	0.000531	0.0149	CcSEcCtD
Mianserin—Tinnitus—Temozolomide—malignant glioma	0.00053	0.0148	CcSEcCtD
Mianserin—Cardiac disorder—Temozolomide—malignant glioma	0.000528	0.0148	CcSEcCtD
Mianserin—DRD2—telencephalon—malignant glioma	0.000519	0.00429	CbGeAlD
Mianserin—Angiopathy—Temozolomide—malignant glioma	0.000516	0.0144	CcSEcCtD
Mianserin—Mental disorder—Carmustine—malignant glioma	0.000516	0.0144	CcSEcCtD
Mianserin—Mediastinal disorder—Temozolomide—malignant glioma	0.000513	0.0143	CcSEcCtD
Mianserin—SLC6A3—midbrain—malignant glioma	0.000507	0.00419	CbGeAlD
Mianserin—ADRA2C—telencephalon—malignant glioma	0.000505	0.00417	CbGeAlD
Mianserin—Mental disorder—Temozolomide—malignant glioma	0.000498	0.0139	CcSEcCtD
Mianserin—HTR1D—midbrain—malignant glioma	0.000495	0.00409	CbGeAlD
Mianserin—SLC6A3—spinal cord—malignant glioma	0.000495	0.00409	CbGeAlD
Mianserin—OPRK1—brain—malignant glioma	0.000494	0.00408	CbGeAlD
Mianserin—HTR2C—midbrain—malignant glioma	0.000491	0.00405	CbGeAlD
Mianserin—HRH2—brain—malignant glioma	0.000488	0.00403	CbGeAlD
Mianserin—Tremor—Carmustine—malignant glioma	0.00048	0.0134	CcSEcCtD
Mianserin—HTR2C—spinal cord—malignant glioma	0.000479	0.00395	CbGeAlD
Mianserin—Amitriptyline—NTRK1—malignant glioma	0.000478	0.0966	CrCbGaD
Mianserin—Anaemia—Carmustine—malignant glioma	0.000473	0.0132	CcSEcCtD
Mianserin—Agitation—Carmustine—malignant glioma	0.000471	0.0132	CcSEcCtD
Mianserin—SLC6A4—midbrain—malignant glioma	0.000465	0.00384	CbGeAlD
Mianserin—Tremor—Temozolomide—malignant glioma	0.000464	0.013	CcSEcCtD
Mianserin—Leukopenia—Carmustine—malignant glioma	0.000459	0.0128	CcSEcCtD
Mianserin—Anaemia—Temozolomide—malignant glioma	0.000458	0.0128	CcSEcCtD
Mianserin—Agitation—Temozolomide—malignant glioma	0.000455	0.0127	CcSEcCtD
Mianserin—SLC6A4—spinal cord—malignant glioma	0.000454	0.00375	CbGeAlD
Mianserin—SLC6A2—medulla oblongata—malignant glioma	0.000448	0.0037	CbGeAlD
Mianserin—Vertigo—Temozolomide—malignant glioma	0.000445	0.0124	CcSEcCtD
Mianserin—Convulsion—Carmustine—malignant glioma	0.000444	0.0124	CcSEcCtD
Mianserin—Leukopenia—Temozolomide—malignant glioma	0.000443	0.0124	CcSEcCtD
Mianserin—Hypertension—Carmustine—malignant glioma	0.000442	0.0124	CcSEcCtD
Mianserin—Myalgia—Carmustine—malignant glioma	0.000436	0.0122	CcSEcCtD
Mianserin—HTR7—medulla oblongata—malignant glioma	0.000432	0.00357	CbGeAlD
Mianserin—Convulsion—Temozolomide—malignant glioma	0.000429	0.012	CcSEcCtD
Mianserin—Hypertension—Temozolomide—malignant glioma	0.000427	0.012	CcSEcCtD
Mianserin—Confusional state—Carmustine—malignant glioma	0.000422	0.0118	CcSEcCtD
Mianserin—Myalgia—Temozolomide—malignant glioma	0.000421	0.0118	CcSEcCtD
Mianserin—Arthralgia—Temozolomide—malignant glioma	0.000421	0.0118	CcSEcCtD
Mianserin—HTR2A—embryo—malignant glioma	0.000421	0.00348	CbGeAlD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000419	0.0117	CcSEcCtD
Mianserin—Oedema—Carmustine—malignant glioma	0.000418	0.0117	CcSEcCtD
Mianserin—HTR1A—midbrain—malignant glioma	0.000413	0.00341	CbGeAlD
Mianserin—Dry mouth—Temozolomide—malignant glioma	0.000412	0.0115	CcSEcCtD
Mianserin—HRH1—telencephalon—malignant glioma	0.00041	0.00339	CbGeAlD
Mianserin—Thrombocytopenia—Carmustine—malignant glioma	0.000409	0.0115	CcSEcCtD
Mianserin—Tachycardia—Carmustine—malignant glioma	0.000408	0.0114	CcSEcCtD
Mianserin—Confusional state—Temozolomide—malignant glioma	0.000407	0.0114	CcSEcCtD
Mianserin—Oedema—Temozolomide—malignant glioma	0.000404	0.0113	CcSEcCtD
Mianserin—ADRA2A—telencephalon—malignant glioma	0.000403	0.00333	CbGeAlD
Mianserin—HTR1A—spinal cord—malignant glioma	0.000403	0.00333	CbGeAlD
Mianserin—SLC6A3—central nervous system—malignant glioma	0.000402	0.00332	CbGeAlD
Mianserin—ADRA2C—medulla oblongata—malignant glioma	0.000397	0.00328	CbGeAlD
Mianserin—Nervous system disorder—Temozolomide—malignant glioma	0.000396	0.0111	CcSEcCtD
Mianserin—Thrombocytopenia—Temozolomide—malignant glioma	0.000396	0.0111	CcSEcCtD
Mianserin—HTR7—midbrain—malignant glioma	0.000395	0.00326	CbGeAlD
Mianserin—SLC6A3—cerebellum—malignant glioma	0.000393	0.00324	CbGeAlD
Mianserin—Skin disorder—Temozolomide—malignant glioma	0.000392	0.011	CcSEcCtD
Mianserin—HTR1D—central nervous system—malignant glioma	0.000392	0.00324	CbGeAlD
Mianserin—Mirtazapine—SLC6A3—malignant glioma	0.000392	0.0791	CrCbGaD
Mianserin—Hypotension—Carmustine—malignant glioma	0.000391	0.0109	CcSEcCtD
Mianserin—HTR2C—central nervous system—malignant glioma	0.000388	0.00321	CbGeAlD
Mianserin—HTR2A—brainstem—malignant glioma	0.000386	0.00319	CbGeAlD
Mianserin—HTR7—spinal cord—malignant glioma	0.000385	0.00318	CbGeAlD
Mianserin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000381	0.0107	CcSEcCtD
Mianserin—Paraesthesia—Carmustine—malignant glioma	0.000375	0.0105	CcSEcCtD
Mianserin—DRD2—midbrain—malignant glioma	0.000373	0.00308	CbGeAlD
Mianserin—HTR2A—retina—malignant glioma	0.000372	0.00308	CbGeAlD
Mianserin—Somnolence—Carmustine—malignant glioma	0.000372	0.0104	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000368	0.0103	CcSEcCtD
Mianserin—SLC6A4—central nervous system—malignant glioma	0.000368	0.00304	CbGeAlD
Mianserin—HTR2B—central nervous system—malignant glioma	0.000365	0.00301	CbGeAlD
Mianserin—Paraesthesia—Temozolomide—malignant glioma	0.000363	0.0101	CcSEcCtD
Mianserin—ADRA2C—midbrain—malignant glioma	0.000363	0.003	CbGeAlD
Mianserin—Gastrointestinal disorder—Carmustine—malignant glioma	0.000361	0.0101	CcSEcCtD
Mianserin—Somnolence—Temozolomide—malignant glioma	0.000359	0.01	CcSEcCtD
Mianserin—Constipation—Carmustine—malignant glioma	0.000358	0.01	CcSEcCtD
Mianserin—ADRA2C—spinal cord—malignant glioma	0.000354	0.00292	CbGeAlD
Mianserin—CYP2D6—brainstem—malignant glioma	0.000352	0.0029	CbGeAlD
Mianserin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000349	0.00976	CcSEcCtD
Mianserin—Fatigue—Temozolomide—malignant glioma	0.000348	0.00974	CcSEcCtD
Mianserin—Constipation—Temozolomide—malignant glioma	0.000345	0.00967	CcSEcCtD
Mianserin—Feeling abnormal—Carmustine—malignant glioma	0.000345	0.00964	CcSEcCtD
Mianserin—HTR2A—telencephalon—malignant glioma	0.000343	0.00283	CbGeAlD
Mianserin—Desipramine—CYP2C18—malignant glioma	0.000335	0.0676	CrCbGaD
Mianserin—Feeling abnormal—Temozolomide—malignant glioma	0.000333	0.00931	CcSEcCtD
Mianserin—HTR1A—central nervous system—malignant glioma	0.000327	0.0027	CbGeAlD
Mianserin—SLC6A2—central nervous system—malignant glioma	0.000324	0.00268	CbGeAlD
Mianserin—HTR1A—cerebellum—malignant glioma	0.000319	0.00264	CbGeAlD
Mianserin—SLC6A3—brain—malignant glioma	0.000319	0.00263	CbGeAlD
Mianserin—ADRA2A—medulla oblongata—malignant glioma	0.000317	0.00261	CbGeAlD
Mianserin—HTR7—central nervous system—malignant glioma	0.000312	0.00258	CbGeAlD
Mianserin—CYP2D6—telencephalon—malignant glioma	0.000312	0.00258	CbGeAlD
Mianserin—HTR1D—brain—malignant glioma	0.000311	0.00257	CbGeAlD
Mianserin—HTR2C—brain—malignant glioma	0.000308	0.00255	CbGeAlD
Mianserin—HTR7—cerebellum—malignant glioma	0.000305	0.00252	CbGeAlD
Mianserin—Asthenia—Carmustine—malignant glioma	0.0003	0.00839	CcSEcCtD
Mianserin—DRD2—central nervous system—malignant glioma	0.000295	0.00244	CbGeAlD
Mianserin—SLC6A4—brain—malignant glioma	0.000292	0.00241	CbGeAlD
Mianserin—Asthenia—Temozolomide—malignant glioma	0.00029	0.00811	CcSEcCtD
Mianserin—HTR2B—brain—malignant glioma	0.00029	0.00239	CbGeAlD
Mianserin—ADRA2A—midbrain—malignant glioma	0.000289	0.00239	CbGeAlD
Mianserin—DRD2—cerebellum—malignant glioma	0.000289	0.00238	CbGeAlD
Mianserin—ADRA2C—central nervous system—malignant glioma	0.000287	0.00237	CbGeAlD
Mianserin—Pruritus—Temozolomide—malignant glioma	0.000286	0.008	CcSEcCtD
Mianserin—Imipramine—CYP2C18—malignant glioma	0.000284	0.0574	CrCbGaD
Mianserin—ADRA2A—spinal cord—malignant glioma	0.000282	0.00233	CbGeAlD
Mianserin—ADRA2C—cerebellum—malignant glioma	0.000281	0.00232	CbGeAlD
Mianserin—Dizziness—Carmustine—malignant glioma	0.000276	0.00773	CcSEcCtD
Mianserin—HTR2A—medulla oblongata—malignant glioma	0.000269	0.00222	CbGeAlD
Mianserin—Dizziness—Temozolomide—malignant glioma	0.000267	0.00747	CcSEcCtD
Mianserin—Rash—Carmustine—malignant glioma	0.000264	0.00737	CcSEcCtD
Mianserin—Dermatitis—Carmustine—malignant glioma	0.000263	0.00737	CcSEcCtD
Mianserin—Headache—Carmustine—malignant glioma	0.000262	0.00733	CcSEcCtD
Mianserin—HTR1A—brain—malignant glioma	0.000259	0.00214	CbGeAlD
Mianserin—SLC6A2—brain—malignant glioma	0.000257	0.00212	CbGeAlD
Mianserin—Rash—Temozolomide—malignant glioma	0.000255	0.00713	CcSEcCtD
Mianserin—Dermatitis—Temozolomide—malignant glioma	0.000254	0.00712	CcSEcCtD
Mianserin—Headache—Temozolomide—malignant glioma	0.000253	0.00708	CcSEcCtD
Mianserin—Desipramine—CYP2B6—malignant glioma	0.000249	0.0502	CrCbGaD
Mianserin—HTR7—brain—malignant glioma	0.000248	0.00205	CbGeAlD
Mianserin—HTR2A—midbrain—malignant glioma	0.000246	0.00203	CbGeAlD
Mianserin—Trimipramine—SLC6A3—malignant glioma	0.000242	0.0489	CrCbGaD
Mianserin—HTR2A—spinal cord—malignant glioma	0.00024	0.00198	CbGeAlD
Mianserin—CYP2B6—central nervous system—malignant glioma	0.000239	0.00197	CbGeAlD
Mianserin—DRD2—brain—malignant glioma	0.000234	0.00194	CbGeAlD
Mianserin—HRH1—central nervous system—malignant glioma	0.000233	0.00193	CbGeAlD
Mianserin—ADRA2A—central nervous system—malignant glioma	0.000229	0.00189	CbGeAlD
Mianserin—ADRA2C—brain—malignant glioma	0.000228	0.00188	CbGeAlD
Mianserin—ADRA2A—cerebellum—malignant glioma	0.000224	0.00185	CbGeAlD
Mianserin—Desipramine—SLC6A3—malignant glioma	0.000212	0.0428	CrCbGaD
Mianserin—Imipramine—CYP2B6—malignant glioma	0.000211	0.0426	CrCbGaD
Mianserin—Amitriptyline—CYP2B6—malignant glioma	0.000209	0.0423	CrCbGaD
Mianserin—Nortriptyline—PTGS1—malignant glioma	0.000199	0.0401	CrCbGaD
Mianserin—HTR2A—central nervous system—malignant glioma	0.000195	0.00161	CbGeAlD
Mianserin—HTR2A—cerebellum—malignant glioma	0.00019	0.00157	CbGeAlD
Mianserin—CYP2B6—brain—malignant glioma	0.00019	0.00157	CbGeAlD
Mianserin—HRH1—brain—malignant glioma	0.000185	0.00153	CbGeAlD
Mianserin—ADRA2A—brain—malignant glioma	0.000182	0.0015	CbGeAlD
Mianserin—CYP3A4—central nervous system—malignant glioma	0.00018	0.00149	CbGeAlD
Mianserin—Imipramine—SLC6A3—malignant glioma	0.00018	0.0363	CrCbGaD
Mianserin—CYP2D6—central nervous system—malignant glioma	0.000177	0.00147	CbGeAlD
Mianserin—CYP2D6—cerebellum—malignant glioma	0.000173	0.00143	CbGeAlD
Mianserin—HTR2A—brain—malignant glioma	0.000155	0.00128	CbGeAlD
Mianserin—CYP2D6—brain—malignant glioma	0.000141	0.00116	CbGeAlD
Mianserin—CYP1A2—Metabolism—GSTP1—malignant glioma	4.76e-06	5.62e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—PTEN—malignant glioma	4.75e-06	5.61e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	4.75e-06	5.61e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—RAF1—malignant glioma	4.75e-06	5.61e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PIK3CD—malignant glioma	4.74e-06	5.6e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—KRAS—malignant glioma	4.73e-06	5.58e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MYC—malignant glioma	4.72e-06	5.57e-05	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	4.71e-06	5.56e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—ERBB2—malignant glioma	4.7e-06	5.55e-05	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	4.7e-06	5.54e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—KRAS—malignant glioma	4.65e-06	5.49e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MYC—malignant glioma	4.65e-06	5.49e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MYC—malignant glioma	4.65e-06	5.48e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—KRAS—malignant glioma	4.64e-06	5.48e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PIK3CB—malignant glioma	4.64e-06	5.48e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—AKT1—malignant glioma	4.64e-06	5.47e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CAT—malignant glioma	4.63e-06	5.47e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—FGF2—malignant glioma	4.62e-06	5.46e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—BRAF—malignant glioma	4.62e-06	5.46e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—EGFR—malignant glioma	4.62e-06	5.45e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MYC—malignant glioma	4.62e-06	5.45e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—BCHE—malignant glioma	4.61e-06	5.45e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—VEGFA—malignant glioma	4.61e-06	5.45e-05	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	4.61e-06	5.44e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CXCL8—malignant glioma	4.61e-06	5.44e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CXCL8—malignant glioma	4.58e-06	5.41e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—STAT3—malignant glioma	4.57e-06	5.39e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CASP3—malignant glioma	4.57e-06	5.39e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL2—malignant glioma	4.56e-06	5.38e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.56e-06	5.38e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—FGF2—malignant glioma	4.55e-06	5.37e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—EGFR—malignant glioma	4.55e-06	5.37e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—EGFR—malignant glioma	4.54e-06	5.36e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—FGF2—malignant glioma	4.54e-06	5.36e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—EGFR—malignant glioma	4.51e-06	5.33e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PIK3CB—malignant glioma	4.51e-06	5.32e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKT2—malignant glioma	4.5e-06	5.31e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	4.48e-06	5.29e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTGS2—malignant glioma	4.47e-06	5.27e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CXCL8—malignant glioma	4.46e-06	5.26e-05	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	4.45e-06	5.25e-05	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	4.43e-06	5.23e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CASP3—malignant glioma	4.41e-06	5.21e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL2—malignant glioma	4.4e-06	5.2e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CASP3—malignant glioma	4.39e-06	5.18e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL2—malignant glioma	4.38e-06	5.17e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—NCOR1—malignant glioma	4.37e-06	5.16e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—KRAS—malignant glioma	4.36e-06	5.15e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	4.34e-06	5.13e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MDM2—malignant glioma	4.33e-06	5.11e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	4.32e-06	5.1e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MMP9—malignant glioma	4.32e-06	5.1e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—RAF1—malignant glioma	4.31e-06	5.09e-05	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	4.31e-06	5.08e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—KRAS—malignant glioma	4.3e-06	5.07e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—VEGFA—malignant glioma	4.29e-06	5.07e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—KRAS—malignant glioma	4.29e-06	5.07e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—PTEN—malignant glioma	4.29e-06	5.07e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	4.28e-06	5.06e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	4.27e-06	5.05e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CASP3—malignant glioma	4.27e-06	5.04e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—ERBB2—malignant glioma	4.27e-06	5.04e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	4.26e-06	5.04e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—KRAS—malignant glioma	4.26e-06	5.04e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL2—malignant glioma	4.26e-06	5.03e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MDM2—malignant glioma	4.26e-06	5.03e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—STAT3—malignant glioma	4.25e-06	5.02e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MDM2—malignant glioma	4.25e-06	5.02e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MYC—malignant glioma	4.25e-06	5.01e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—RAF1—malignant glioma	4.24e-06	5.01e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—RAF1—malignant glioma	4.23e-06	5e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	4.23e-06	5e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PIK3CB—malignant glioma	4.22e-06	4.99e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PIK3CB—malignant glioma	4.21e-06	4.97e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CAV1—malignant glioma	4.21e-06	4.97e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—AKT1—malignant glioma	4.21e-06	4.96e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—ERBB2—malignant glioma	4.2e-06	4.96e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—ERBB2—malignant glioma	4.19e-06	4.94e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	4.19e-06	4.94e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTGS2—malignant glioma	4.19e-06	4.94e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MMP9—malignant glioma	4.17e-06	4.92e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—EGFR—malignant glioma	4.15e-06	4.9e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MMP9—malignant glioma	4.15e-06	4.89e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—PTEN—malignant glioma	4.14e-06	4.89e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	4.14e-06	4.89e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—FGF2—malignant glioma	4.14e-06	4.89e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PIK3CB—malignant glioma	4.13e-06	4.88e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—PTEN—malignant glioma	4.12e-06	4.87e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CXCL8—malignant glioma	4.05e-06	4.78e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—AKT1—malignant glioma	4.04e-06	4.77e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MMP9—malignant glioma	4.03e-06	4.76e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—AKT1—malignant glioma	4.02e-06	4.75e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PTEN—malignant glioma	4.01e-06	4.73e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—PIK3CA—malignant glioma	4.01e-06	4.73e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CXCL8—malignant glioma	3.98e-06	4.7e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CXCL8—malignant glioma	3.97e-06	4.69e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MYC—malignant glioma	3.95e-06	4.66e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—PIK3CA—malignant glioma	3.95e-06	4.66e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—PIK3CA—malignant glioma	3.94e-06	4.66e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—KRAS—malignant glioma	3.92e-06	4.63e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	3.92e-06	4.63e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	3.91e-06	4.62e-05	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—AKT1—malignant glioma	3.91e-06	4.61e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTEN—malignant glioma	3.89e-06	4.6e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	3.89e-06	4.59e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	3.88e-06	4.58e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—malignant glioma	3.88e-06	4.58e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MDM2—malignant glioma	3.87e-06	4.57e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CASP3—malignant glioma	3.87e-06	4.57e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL2—malignant glioma	3.87e-06	4.56e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—EGFR—malignant glioma	3.86e-06	4.56e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—RAF1—malignant glioma	3.86e-06	4.56e-05	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	3.84e-06	4.54e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—STAT3—malignant glioma	3.84e-06	4.53e-05	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—AKT1—malignant glioma	3.84e-06	4.53e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.83e-06	4.52e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—malignant glioma	3.82e-06	4.51e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	3.82e-06	4.51e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—malignant glioma	3.82e-06	4.5e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CASP3—malignant glioma	3.81e-06	4.5e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL2—malignant glioma	3.8e-06	4.49e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CASP3—malignant glioma	3.8e-06	4.49e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL2—malignant glioma	3.8e-06	4.48e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—malignant glioma	3.79e-06	4.48e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	3.77e-06	4.45e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—malignant glioma	3.74e-06	4.42e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—malignant glioma	3.72e-06	4.39e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—STAT3—malignant glioma	3.71e-06	4.37e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PPARG—malignant glioma	3.7e-06	4.37e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—STAT3—malignant glioma	3.69e-06	4.35e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTP1—malignant glioma	3.67e-06	4.34e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MMP9—malignant glioma	3.66e-06	4.32e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTEN—malignant glioma	3.65e-06	4.31e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—KRAS—malignant glioma	3.65e-06	4.31e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PTEN—malignant glioma	3.64e-06	4.29e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	3.62e-06	4.28e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	3.62e-06	4.27e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	3.6e-06	4.25e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MMP9—malignant glioma	3.6e-06	4.25e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MMP9—malignant glioma	3.59e-06	4.24e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—STAT3—malignant glioma	3.59e-06	4.23e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PTEN—malignant glioma	3.58e-06	4.23e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CAT—malignant glioma	3.57e-06	4.22e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PTEN—malignant glioma	3.57e-06	4.22e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MYC—malignant glioma	3.57e-06	4.21e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CAV1—malignant glioma	3.56e-06	4.21e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—AKT1—malignant glioma	3.55e-06	4.19e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	3.5e-06	4.13e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—AKT1—malignant glioma	3.49e-06	4.12e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EGFR—malignant glioma	3.49e-06	4.12e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—malignant glioma	3.49e-06	4.12e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—AKT1—malignant glioma	3.48e-06	4.11e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CASP3—malignant glioma	3.47e-06	4.09e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL2—malignant glioma	3.46e-06	4.09e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MYC—malignant glioma	3.44e-06	4.06e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MYC—malignant glioma	3.43e-06	4.04e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.41e-06	4.02e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PIK3CA—malignant glioma	3.38e-06	3.99e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NCOR1—malignant glioma	3.37e-06	3.98e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.37e-06	3.98e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EGFR—malignant glioma	3.37e-06	3.98e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—PIK3CA—malignant glioma	3.35e-06	3.96e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EGFR—malignant glioma	3.35e-06	3.96e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MYC—malignant glioma	3.33e-06	3.93e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—KRAS—malignant glioma	3.3e-06	3.89e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—malignant glioma	3.29e-06	3.88e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MMP9—malignant glioma	3.28e-06	3.87e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—AKT1—malignant glioma	3.27e-06	3.86e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EGFR—malignant glioma	3.26e-06	3.85e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PTEN—malignant glioma	3.26e-06	3.84e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—STAT3—malignant glioma	3.25e-06	3.84e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CG—malignant glioma	3.25e-06	3.83e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—malignant glioma	3.24e-06	3.83e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—malignant glioma	3.23e-06	3.82e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—malignant glioma	3.23e-06	3.81e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—AKT1—malignant glioma	3.23e-06	3.81e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—AKT1—malignant glioma	3.22e-06	3.8e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—STAT3—malignant glioma	3.2e-06	3.78e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—AKT1—malignant glioma	3.2e-06	3.78e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—STAT3—malignant glioma	3.19e-06	3.77e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—KRAS—malignant glioma	3.18e-06	3.76e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	3.18e-06	3.75e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—KRAS—malignant glioma	3.16e-06	3.74e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PPARG—malignant glioma	3.13e-06	3.7e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—KRAS—malignant glioma	3.08e-06	3.63e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	3.03e-06	3.57e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MYC—malignant glioma	3.02e-06	3.57e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MYC—malignant glioma	2.97e-06	3.51e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MYC—malignant glioma	2.97e-06	3.5e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EGFR—malignant glioma	2.96e-06	3.49e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—AKT1—malignant glioma	2.94e-06	3.48e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	2.94e-06	3.47e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.94e-06	3.47e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—malignant glioma	2.93e-06	3.46e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	2.92e-06	3.45e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—STAT3—malignant glioma	2.91e-06	3.44e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTGS2—malignant glioma	2.91e-06	3.44e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EGFR—malignant glioma	2.91e-06	3.43e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	2.91e-06	3.43e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EGFR—malignant glioma	2.9e-06	3.43e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.85e-06	3.37e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	2.83e-06	3.34e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—malignant glioma	2.83e-06	3.34e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—malignant glioma	2.81e-06	3.32e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—KRAS—malignant glioma	2.79e-06	3.3e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—AKT1—malignant glioma	2.76e-06	3.26e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CAV1—malignant glioma	2.75e-06	3.25e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—KRAS—malignant glioma	2.75e-06	3.24e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PIK3CA—malignant glioma	2.75e-06	3.24e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—KRAS—malignant glioma	2.74e-06	3.24e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—AKT1—malignant glioma	2.74e-06	3.23e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—malignant glioma	2.74e-06	3.23e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MYC—malignant glioma	2.71e-06	3.19e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EGFR—malignant glioma	2.65e-06	3.12e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PIK3CA—malignant glioma	2.58e-06	3.04e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PIK3CA—malignant glioma	2.57e-06	3.03e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTEN—malignant glioma	2.54e-06	3e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	2.52e-06	2.98e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PIK3CA—malignant glioma	2.52e-06	2.97e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.51e-06	2.96e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—KRAS—malignant glioma	2.5e-06	2.95e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.49e-06	2.94e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—malignant glioma	2.48e-06	2.93e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—AKT1—malignant glioma	2.47e-06	2.92e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTGS2—malignant glioma	2.46e-06	2.91e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—malignant glioma	2.44e-06	2.88e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—malignant glioma	2.44e-06	2.88e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPARG—malignant glioma	2.42e-06	2.85e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—AKT1—malignant glioma	2.39e-06	2.82e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—AKT1—malignant glioma	2.38e-06	2.8e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—AKT1—malignant glioma	2.31e-06	2.73e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	2.3e-06	2.71e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—AKT1—malignant glioma	2.24e-06	2.65e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—malignant glioma	2.22e-06	2.62e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.2e-06	2.6e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTEN—malignant glioma	2.15e-06	2.54e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—AKT1—malignant glioma	2.1e-06	2.48e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—AKT1—malignant glioma	2.1e-06	2.47e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—AKT1—malignant glioma	2.06e-06	2.44e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—AKT1—malignant glioma	2.06e-06	2.43e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.92e-06	2.27e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTGS2—malignant glioma	1.9e-06	2.25e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKT1—malignant glioma	1.88e-06	2.22e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.79e-06	2.11e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTEN—malignant glioma	1.66e-06	1.96e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.52e-06	1.79e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—AKT1—malignant glioma	1.46e-06	1.73e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AKT1—malignant glioma	1.24e-06	1.46e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.17e-06	1.38e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AKT1—malignant glioma	9.56e-07	1.13e-05	CbGpPWpGaD
